Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Reference100 articles.
1. Exuzides A, Reddy SR, Chang E, Paydar C, Yohrling G (2020) Epidemiology of Huntington’s disease in the US Medicaid population. Prevalence 5:10.10
2. Kumar V, Singh A (2021) Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: an opinion. EXCLI J 20:1086
3. Chakraborty J, Nthenge-Ngumbau D, Rajamma U, Mohanakumar K (2014) Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington’s disease. Behav Brain Res 264:91–104
4. Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington’s disease. J Psychiatry Neurosci 31(1):21
5. Richfield EK, Herkenham M (1994) Selective vulnerability in Huntington’s disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36(4):577–584
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献